Detalhe da pesquisa
1.
Antiemetic use among pregnant women in the United States: the escalating use of ondansetron.
Pharmacoepidemiol Drug Saf
; 26(5): 592-596, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28220993
2.
Assessment of health risks resulting from early-life exposures: Are current chemical toxicity testing protocols and risk assessment methods adequate?
Crit Rev Toxicol
; 45(3): 219-44, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25687245
3.
Assessing congenital malformation risk from medications used in pregnancy: The contribution of NBDPS in pregnancy labeling of prescription drug products.
Birth Defects Res A Clin Mol Teratol
; 103(8): 718-20, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26223007
4.
Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011.
Pharmacoepidemiol Drug Saf
; 22(3): 324-8, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23359404
5.
Monitoring for teratogenic signals: pregnancy registries and surveillance methods.
Am J Med Genet C Semin Med Genet
; 157C(3): 209-14, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21766431
6.
Essential fatty acid supplementation of DHA and ARA and effects on neurodevelopment across animal species: a review of the literature.
Birth Defects Res B Dev Reprod Toxicol
; 92(3): 240-50, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21678548
7.
Juvenile animal studies and pediatric drug development retrospective review: use in regulatory decisions and labeling.
Birth Defects Res B Dev Reprod Toxicol
; 92(4): 261-5, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21594977
8.
Reply: To PMID 24881821.
Am J Obstet Gynecol
; 213(1): 116, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25557207
9.
Transcriptomics analysis of early embryonic stem cell differentiation under osteoblast culture conditions: Applications for detection of developmental toxicity.
Reprod Toxicol
; 69: 75-83, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28189605
10.
Developing osteoblasts as an endpoint for the mouse embryonic stem cell test.
Reprod Toxicol
; 53: 131-40, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25929818
11.
Improving access to FDA reviews and documents.
JAMA
; 302(20): 2204-5; author reply 2205, 2009 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19934419
12.
Comparative juvenile safety testing of new therapeutic candidates: relevance of laboratory animal data to children.
J Toxicol Sci
; 34 Suppl 2: SP209-15, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19571471
13.
Pre- and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague-Dawley rats.
Birth Defects Res B Dev Reprod Toxicol
; 71(3): 171-84, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15282738
14.
Comparison of developmental toxicology of aspirin (acetylsalicylic acid) in rats using selected dosing paradigms.
Birth Defects Res B Dev Reprod Toxicol
; 68(1): 27-37, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12852481
15.
Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
Birth Defects Res B Dev Reprod Toxicol
; 68(1): 5-26, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12852480
16.
NSAIDs and developmental toxicity.
Birth Defects Res B Dev Reprod Toxicol
; 68(1): 3-4, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12852479
17.
Species comparison of postnatal bone growth and development.
Birth Defects Res B Dev Reprod Toxicol
; 68(2): 86-110, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12866701
18.
Communicating risks during pregnancy: a workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs.
Birth Defects Res A Clin Mol Teratol
; 70(1): 7-12, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14745889